AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
Detection of microbial volatile organic compounds (MVOCs) produced by moulds on various materials
Authors: Fiedler, K Schutz, E Geh, S
Citation: K. Fiedler et al., Detection of microbial volatile organic compounds (MVOCs) produced by moulds on various materials, INT J HYG E, 204(2-3), 2001, pp. 111-121
General method for site-directed mutagenesis
Authors: Andag, R Schutz, E
Citation: R. Andag et E. Schutz, General method for site-directed mutagenesis, BIOTECHNIQU, 30(3), 2001, pp. 486
Organotypic hippocampal cultures - A model of brain tissue damage in Streptococcus pneumoniae meningitis
Authors: Schmidt, H Tlustochowska, A Stuertz, K Djukic, M Gerber, J Schutz, E Kuhnt, U Nau, R
Citation: H. Schmidt et al., Organotypic hippocampal cultures - A model of brain tissue damage in Streptococcus pneumoniae meningitis, J NEUROIMM, 113(1), 2001, pp. 30-39
Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin
Authors: Gerber, J Smirnov, A Wellmer, A Ragheb, J Prange, J Schutz, E Wettich, K Kalich, S Nau, R
Citation: J. Gerber et al., Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin, ANTIM AG CH, 45(7), 2001, pp. 2169-2172
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients
Authors: Braun, F Schutz, E Peters, B Talaulicar, R Grupp, C Undre, N Schafer, A Armstrong, VW Oellerich, M Ringe, B
Citation: F. Braun et al., Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients, TRANSPLAN P, 33(3), 2001, pp. 2127-2128
Monitoring of mycophenolic acid in pediatric renal transplant recipients
Authors: Armstrong, VW Shipkova, M Schutz, E Weber, L Tonshoff, B Oellerich, M
Citation: Vw. Armstrong et al., Monitoring of mycophenolic acid in pediatric renal transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1040-1043
The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes
Authors: Shipkova, M Wieland, E Schutz, E Wiese, C Niedmann, PD Oellerich, M Armstrong, VW
Citation: M. Shipkova et al., The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes, TRANSPLAN P, 33(1-2), 2001, pp. 1080-1081
A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil
Authors: Ringe, B Braun, F Schutz, E Fuzesi, L Lorf, T Canelo, R Oellerich, M Ramadori, G
Citation: B. Ringe et al., A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil, TRANSPLANT, 71(4), 2001, pp. 508-515
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three timesdaily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
Authors: Kruis, W Schreiber, S Theuer, D Brandes, JW Schutz, E Howaldt, S Krakamp, B Hamling, J Monnikes, H Koop, I Stolte, M Pallant, D Ewald, U
Citation: W. Kruis et al., Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three timesdaily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses, GUT, 49(6), 2001, pp. 783-789
Quantification of mycophenolic acid in plasma samples collected during andimmediately after intravenous administration of mycophenolate mofetil
Authors: Shipkova, M Armstrong, VW Kiehl, MG Niedmann, PD Schutz, E Oellerich, M Wieland, E
Citation: M. Shipkova et al., Quantification of mycophenolic acid in plasma samples collected during andimmediately after intravenous administration of mycophenolate mofetil, CLIN CHEM, 47(8), 2001, pp. 1485-1488
Limitations of genotyping based on amplicon melting temperature
Authors: von Ahsen, N Oellerich, M Schutz, E
Citation: N. Von Ahsen et al., Limitations of genotyping based on amplicon melting temperature, CLIN CHEM, 47(7), 2001, pp. 1331-1332
Oligonucleotide melting temperatures under PCR conditions: Nearest-neighbor corrections for Mg2+, deoxynucleotide triphosphate, and dimethyl sulfoxide concentrations with comparison to alternative empirical formulas
Authors: von Ahsen, N Wittwer, CT Schutz, E
Citation: N. Von Ahsen et al., Oligonucleotide melting temperatures under PCR conditions: Nearest-neighbor corrections for Mg2+, deoxynucleotide triphosphate, and dimethyl sulfoxide concentrations with comparison to alternative empirical formulas, CLIN CHEM, 47(11), 2001, pp. 1956-1961
Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liverperfusion model
Authors: Wieland, E Shipkova, M Schutz, E Braun, F Niedmann, PD Armstrong, VW Ringe, B Svinarov, DA Oellerich, M
Citation: E. Wieland et al., Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liverperfusion model, CLIN BIOCH, 34(1), 2001, pp. 53-57
Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases
Authors: Pickenpack, A Straub, RH Distler, O Hammond, A Oellerich, M Scholmerich, J Lang, B Schutz, E
Citation: A. Pickenpack et al., Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases, RHEUMATOLOG, 39(12), 2000, pp. 1435-1436
Fritz Reuter's place in 19th century German literature
Authors: Schutz, E
Citation: E. Schutz, Fritz Reuter's place in 19th century German literature, Z GERMAN, 10(2), 2000, pp. 379-380
Literary perceptions of turns of centuries - Preliminary note
Authors: Kosenina, A Schutz, E
Citation: A. Kosenina et E. Schutz, Literary perceptions of turns of centuries - Preliminary note, Z GERMAN, 10(1), 2000, pp. 7-10
A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome
Authors: Bardhan, KD Bodemar, G Geldof, H Schutz, E Heath, A Mills, JG Jacques, LA
Citation: Kd. Bardhan et al., A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome, ALIM PHARM, 14(1), 2000, pp. 23-34
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring (vol 1, pg 20, 2000)
Authors: Oellerich, M Shipkova, M Schutz, E Wieland, E Weber, L Tonshoff, B Armstrong, VW
Citation: M. Oellerich et al., Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring (vol 1, pg 20, 2000), THER DRUG M, 22(4), 2000, pp. 500-500
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring
Authors: Oellerich, M Shipkova, M Schutz, E Wieland, E Weber, L Tonshoff, B Armstrong, VW
Citation: M. Oellerich et al., Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring, THER DRUG M, 22(1), 2000, pp. 20-26
Evaluation of an immunoassay for mycophenolic acid
Authors: Schutz, E Shipkova, M Wieland, E Niedmann, PD Armstrong, VW Oellerich, M
Citation: E. Schutz et al., Evaluation of an immunoassay for mycophenolic acid, THER DRUG M, 22(1), 2000, pp. 141-142
Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation
Authors: von Ahsen, N Lewczuk, P Schutz, E Oellerich, M Ehrenreich, H
Citation: N. Von Ahsen et al., Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation, THROMB RES, 99(6), 2000, pp. 549-556
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk"
Authors: Braun, F Lorf, T Schutz, E Canelo, R Hanack, U Dopkens, K Sattler, B Grupp, C Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk", TRANSPLAN P, 32(7), 2000, pp. 1688-1688
An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs
Authors: Braun, F Christians, U Laabs, S Elias, K Shipkova, M Schutz, E Ringe, B
Citation: F. Braun et al., An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs, TRANSPLAN P, 32(7), 2000, pp. 1999-1999
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk"
Authors: Braun, F Lorf, T Schutz, E Canelo, R Hanack, U Dopkens, K Sattler, B Grupp, C Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk", TRANSPLAN P, 32(7), 2000, pp. 2535-2535
An ex vivo model to study the intestinal biotransformation of immunosuppressives
Authors: Braun, F Christians, U Laabs, S Elias, K Shipkova, M Schutz, E Ringe, B
Citation: F. Braun et al., An ex vivo model to study the intestinal biotransformation of immunosuppressives, TRANSPLAN P, 32(7), 2000, pp. 2536-2536
Risultati: 1-25 | 26-50 | 51-60